LADAR 6000: good but time consuming

Article

Although the LADAR 6000 (Alcon) is accurate and safe, the need for pharmacological mydriasis and the use of a nomogram result in a more time consuming surgical procedure.

Although the LADAR 6000 (Alcon) is accurate and safe, the need for pharmacological mydriasis and the use of a nomogram result in a more time consuming surgical procedure, according to Joaquim Murta and colleagues from Coimbra University, Portugal.

A total of 300 consecutive eyes underwent refractive surgery with the LADAR 6000. Of those, 245 were submitted to photorefractive keratectomy (PRK) to correct a manifest spheroequivalent refractive error (MSRE) of -5.5+4.3 D, with a cylinder ranging from -4.50 to +3.50 D. Fifty-five eyes were submitted to LASIK using the Zyoptix XP microkeratome (Bausch & Lomb) to correct MSRE of -0.75 to -9.29 with a cylinder ranging from 0.00 to -5.50 D.

Following PRK, uncorrected visual acuity (UCVA) was 0.9, best spectacle corrected visual acuity (BSCVA) was 1.0 and MSRE was 0.00. The eyes which underwent LASIK reached a UCVA of 0.7, a BSCVA of 0.9 and a MSRE of 0.4. Just one eye lost two lines of BSCVA due to adenoviral keratoconjunctivitis.

Dr Murta concluded that the LADAR 6000 offers good results but is a time consuming procedure.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.